Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination
Unique ID
C000629984
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629984
Entry Term(s)
Symfi
Symfi Lo
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Anti-Retroviral Agents
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Lamivudine
*Benzoxazines
*Tenofovir
Frequency
1
Note
once-daily fixed-dose antiretroviral drug combination for treatment of HIV infection; Symfi Lo contains a lower dose of efavirenz
Source
Med Lett Drugs Ther. 2019 Jan 14;61(1563):e8-e10.
Date of Entry
2019/02/22
Revision Date
2019/02/22
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination Preferred
Symfi Narrower
Symfi Lo Narrower
page delivered in 0.004s